StockData
Odyssey Health, Inc. logo

Odyssey Health, Inc. (ODYY) stock

ODYYOTCSurgical & Medical Instruments & ApparatusFiscal year ends July 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 0/30
$0.01−0.00 (-16.25%)

Close on Oct 19, 2026Market cap $746.34KP/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal , balances at Jul 31, 2026

Valuation

Market cap
$746.34K
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Net income
-$5.73M
EPS, diluted
-$0.05
Book value per share
-$0.11
Diluted shares
111M

Trading

Previous close
$0.01
Open
$0.01
Day's range
$0.01 – $0.01
Volume
26,030
Average volume (20 days)
78,912

Market cap history

Month-end market cap since 2021, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodODYYS&P 500DifferenceODYY per yearS&P 500 per year
1 month-57.3%+0.6%−58.0 pts
3 months+4.7%+3.4%+1.3 pts
Year to date-79.6%+13.3%−92.9 pts
1 year-93.6%+16.6%−110.2 pts
3 years-93.3%+86.4%−179.7 pts-59.4%+23.1%
5 years-97.9%+81.9%−179.8 pts-53.9%+12.7%

Thirteen years at a glance

Fiscal years 2014 to 2026, USD

Revenue

–

Gross profit

–

Operating income

-$912.99K

Net income

-$5.73M

EPS, diluted

-$0.05

Free cash flow

–
Reported period

Press releases

Releases Odyssey Health filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Odyssey Health

Surgical & Medical Instruments & Apparatus

Odyssey Health, Inc. is a medical technology company focused on acquiring and developing medical devices and technologies designed to address unmet clinical needs. The company operates across a single business segment and is developing two primary product candidates: CardioMap, a non-invasive heart monitoring and screening device intended to detect early signs of coronary heart disease, and Save-A-Life, an emergency choking rescue device designed to clear lodged obstructions from a victim's throat using vacuum suction. Odyssey Health does not currently market or sell any products commercially, as its technologies remain in development and require regulatory clearances, such as Food and Drug Administration approvals, prior to commercialization.

Company profile, executives and history

Odyssey Health stock: common questions

What is Odyssey Health's stock price?

ODYY closed at $0.01 on Oct 19, 2026, down 16.25% on the day.

What is Odyssey Health's market cap?

Odyssey Health was worth $746.34K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is ODYY's P/E ratio?

Odyssey Health lost money over the twelve months to Jul 31, 2026 (diluted EPS -$0.05), so it has no meaningful P/E ratio.

Does Odyssey Health pay a dividend?

No. Odyssey Health has not paid a cash dividend over the last twelve months.

How has ODYY stock performed over the past year?

Including dividends, ODYY returned -93.6% over the past year, against +16.6% for the S&P 500.

Who are Odyssey Health's competitors?

Companies most similar to Odyssey Health by business, industry and size include NUMD, DAVI, OBIO, BEAT, EBRCZ.

See a number that looks wrong?